Mesalazine Effects in Sporadic Colorectal Adenoma Patients

Summary

Several studies indicate that mesalazine might have a preventive effect on recurrence of adenomas in patients with and without inflammatory bowel disease. As mesalazine has limited adverse effects, it is an attractive candidate for chemoprevention. In this study we aim to investigate the antineoplastic properties of mesalazine in patients with sporadic colorectal adenomas.

Timeline

Start

2012-07

Primary completion

2015-06

Completion

2015-06

Drugs

Indications